iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.
企業コードICAD
会社名ICAD Inc
上場日Dec 13, 1984
最高経営責任者「CEO」Ms. Dana R. Brown
従業員数66
証券種類Ordinary Share
決算期末Dec 13
本社所在地98 Spit Brook Rd Ste 100
都市NASHUA
証券取引所Euronext Paris
国United States of America
郵便番号03062-5737
電話番号16038825200
ウェブサイトhttps://www.icadmed.com/
企業コードICAD
上場日Dec 13, 1984
最高経営責任者「CEO」Ms. Dana R. Brown
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし